ABSTRACT The NH2-terminal 134 amino-acid fragment of the reduced-carbamidomethylated human somatotropin molecule is found to react noncovalently with the COOS-terminal 51 amino-adid fragment in solutions of pH 8.4 at 20 to restore full biological activity as evidenced by the rat tibia and pigeon crop-sac assays. In addition, circular dichroism spectra of the recombinant show the conformation to be completely repaired in comparison with that of the native hormone.
The use of plasmin for the partial digestion of somatotropins has been described by Ellis et al. (1) . Chrambach and Yadley (2) reported an 8-fold enhancement of somatotropin activity of human somatotropin (human growth hormone, HGH) produced by plasmin, at the 1970 Endocrine Society annual meeting. Later, Yadley and Chrambach (3) described in detail that digestion of HGH with plasmin leads to a progressive transformation of the hormone to various components of higher electrophoretic mobility and increased prolactin activity. Reagan et al. (4) and Mills et al. (5) reported that hydrolysis of HGH with plasmin did not impair metabolic effects in the rat or in man. A detailed chemical and physical characterization of the cleaved products of HGH by plasmin digestion was not given in any of these studies. Li and Graif (6) reported the isolation and characterization of two biologically active fragments from plasmin digests of HGH. It was shown that these two fragments, Cys(Cam)53-HGH-(1-134) and Cys(Cam)'65,182,189-HGH-(141-191), (Cam is carbamidomethyl) were derived from cleavage of the Arg-Thr (positions 134-135) and the Lys-Gln (positions 140-141) bonds of the hormone molecule (see Fig. 1 ). The isolation and biological characterization of Cys(Cam)53-HGH-(1-134) have also been described by Reagan et al. (7) . Both peptide fragments possess immunoreactivity in complement fixation and radioimmunoassay experiments (8) . In this paper, we report complementation experiments using these two fragments to obtain the recombinant with full growth-promoting and prolactin potency.
MATERIALS AND METHODS
Human somatotropih was isolated from fresh-frozen pituitary glands by the method of Li et al. (9) . Cys(Cam)53- (11) . The concentrations of all solutions were determined spectrophotometrically using the relation A01%1cm,277nm = 0.931. For simplicity this procedure was used regardless of whether the sample contained intact HGH modified by limited digestion with human plasmin (PL-HGH) or was a mixture of PL-HGH and its fragments. Spectra were calculated as mean residue ellipticities using 115 as the mean residue molecular weight in all cases. The contents of a-helix were estimated as previously described (12) .
The growth-promoting activity was determined by the rat tibia test (13) and the prolactin activity by the local crop-sac assay in the pigeon (14, 15) . The fragment mixtute was submitted to exclusion chromatography on Sephadex G-100 and the elution pattern is shown in Fig. 2 . Approximately 25% of the protein appeared in a distinct peak (designated fraction IV), with a Ve/Vo ratio of 2.12. This is precisely the elution position of intact PL-HGH on this same column (18) . It is especially noteworthy that no detectable protein was found at a Ve/Vo ratio of 2.9-3.1, the elution position expected for the free COOHterminal fragment (16) . The CD spectra of the fragment mixture before purification by exclusion chromatography are shown in Fig. 3 . The interesting feature of this spectrum is the appearance of a weak negative band around 298 nm. This band has previously been assigned to the Trp-86 residue in the NH2-terminal fragment (16) . The negative sign of this indole dichroism is characteristic of the conformation of the free fragment and is in sharp contrast to the positive indole dichroism at 292 nm, characteristic of the conformation of intact reducedalkylated PL-HGH or native HGH (16) . However, it can be seen ( Fig. 3 ) that in the spectrum of this incubation mixture, the negative band is not as intense as it would be in a'pure sample of the NH2-terminal fragment, suggesting that the mixture contains overlapping contributions from both positively and negatively dichroic indole groups. The CD spectra of this same sample in the far-UV region indicate an average a-helix content of 45-50%.
The CD spectra of the purified recombinant (fraction IV, Fig. 2 ) are also shown in Fig. 3 and may be compared with the spectrum of a freshly thawed, undissociated sample of intact, reduced-carbamidomethylated PL-HGHI. As 'can be seen, the spectrum of this material in the region of sidechain absorption is not significantly different from that of intact reduced-carbamidomethylated PL-HGH. The complete equivalence of the positive indole dichroism at 292 nm in these two samples is particularly noteworthy. The far-UV spectrum of fraction IV indicates that this material possibly contains a slightly higher content of a-helix (t'60%) than either reduced-carbamidomethylated PL-HGH or native HGH (16, 12) .
It may be seen in Table 1 that the solution containing the two fragments before purification had restored growth-promoting activity from 8 to 60% when compared with the potency of the 134 residue fragment in the tibia test. At the dose tested, the potency of the 51 residue fragment was almost nil. The regeneration of lactogenic activity was also evident in the pigeon crop-sac assay as shown in Table 1 .
The biological activities of the purified recombinant (fraction IV, Fig. 2 ) are summarized in Table 2 . In comparison with the activities of PL-HGH, the recombinant had full growth-promoting and prolactin potency. It is significant that the prolactin activity of the purified recombinant is re- stored from less than 1 to 100% of PL-HGH potency as seen and alkylation of the two disulfide bridges in the presence or in Tables 1 and 2. absence of denaturants cause no alteration of biological activity (18, 19) . Following reduction of the disulfide bridges, the HGH molecule is readily reoxidized to the native hor-HGH is a globular protein with a molecular weight of mone (20) . Removal of' a hexapeptide (residues 135-140; 22,000 (17) and a-helical content of 55% (12) . Reduction tt Relative potency to Cys(Cam)53-HGH-(1-134), 828% with a confidence limit of 441-3077 and X = 0.17. 14 Relative potency to PL-HGH, 8% with a confidence limit of 4-12 and A = 0.12. Table 2 . In addition, the recombinant exhibits complete recovery of immunoreactivity by radioimmunoassay system (C. H. Li and T. Hayashida, unpublished observations). It is important to note that the CD spectra (Fig. 3 ) and elution position (Fig. 2) of the recombinant are identical to those of the native hormone. Apparently the three-dimensional structure of the HGH molecule can be restored to its original conformation by a noncovalent interaction of the NH2-terminal 134-residue fragment with the COOH-terminal 51-residue fragment. Preliminary experiments using the synthetic (22) COOHterminal fragment Cys(Cam)l65l182189-HGH-(141-191) indicate that biological potency can be restored by mixing the synthetic material with the natural NH2-terminal 134-residue fragment as revealed by both tibia test and pigeon cropsac assay. The minimal size of each fragment required for the complementation reaction to generate HGH activity remains to be determined.
It is known (23, 24) that peptide fragments derived from native enzymes are capable of recombination by noncovalent interaction to regenerate enzymic activity. As far as we are aware, this report is the first to describe a case in which two peptide fragments from a protein hormone complement to restore full biological potency. It should also be noted that the complementation reaction herein described was performed using two peptide fragments which were derived from reduction and alkylation of disulfide bridges in the plasmin-modified molecule.
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